US 8809293
Compositions and methods for inhibiting gene expression of hepatitis B virus
granted A61KA61K31/713A61P
Quick answer
US patent 8809293 (Compositions and methods for inhibiting gene expression of hepatitis B virus) held by Arrowhead Madison, Inc. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Madison, Inc.
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/713, A61P, A61P1/16, A61P29/00